140 related articles for article (PubMed ID: 21526489)
1. ICOS gene polymorphisms in B-cell chronic lymphocytic leukemia in the Polish population.
Karabon L; Jedynak A; Tomkiewicz A; Wolowiec D; Kielbinski M; Woszczyk D; Kuliczkowski K; Frydecka I
Folia Histochem Cytobiol; 2011; 49(1):49-54. PubMed ID: 21526489
[TBL] [Abstract][Full Text] [Related]
2. Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with B-cell chronic lymphocytic leukemia in the Polish population.
Suwalska K; Pawlak E; Karabon L; Tomkiewicz A; Dobosz T; Urbaniak-Kujda D; Kuliczkowski K; Wolowiec D; Jedynak A; Frydecka I
Hum Immunol; 2008 Mar; 69(3):193-201. PubMed ID: 18396212
[TBL] [Abstract][Full Text] [Related]
3. Influence of CTLA-4/CD28/ICOS gene polymorphisms on the susceptibility to cervical squamous cell carcinoma and stage of differentiation in the Polish population.
Pawlak E; Karabon L; Wlodarska-Polinska I; Jedynak A; Jonkisz A; Tomkiewicz A; Kornafel J; Stepien M; Ignatowicz A; Lebioda A; Dobosz T; Frydecka I
Hum Immunol; 2010 Feb; 71(2):195-200. PubMed ID: 19913589
[TBL] [Abstract][Full Text] [Related]
4. CTLA-4, CD28, and ICOS gene polymorphism associations with non-small-cell lung cancer.
Karabon L; Pawlak E; Tomkiewicz A; Jedynak A; Passowicz-Muszynska E; Zajda K; Jonkisz A; Jankowska R; Krzakowski M; Frydecka I
Hum Immunol; 2011 Oct; 72(10):947-54. PubMed ID: 21669243
[TBL] [Abstract][Full Text] [Related]
5. CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves' disease and modulates clinical phenotype of disease.
Pawlak-Adamska E; Frydecka I; Bolanowski M; Tomkiewicz A; Jonkisz A; Karabon L; Partyka A; Nowak O; Szalinski M; Daroszewski J
Endocrine; 2017 Jan; 55(1):186-199. PubMed ID: 27638540
[TBL] [Abstract][Full Text] [Related]
6. ICOS gene polymorphisms are associated with sporadic breast cancer: a case-control study.
Xu F; Li D; Zhang Q; Fu Z; Zhang J; Yuan W; Chen S; Pang D; Li D
BMC Cancer; 2011 Sep; 11():392. PubMed ID: 21917182
[TBL] [Abstract][Full Text] [Related]
7. Investigation of
Yang J; Liu J; Chen Y; Tang W; Bo K; Sun Y; Chen J
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31235485
[TBL] [Abstract][Full Text] [Related]
8. Association of Inducible T Cell Costimulator Polymorphisms with Susceptibility and Outcome of Hepatitis B Virus Infection in a Chinese Han Population.
Hu J; Li QL; Hou SH; Peng H; Guo JJ
Scand J Immunol; 2015 Sep; 82(3):275-81. PubMed ID: 26074057
[TBL] [Abstract][Full Text] [Related]
9. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28.
Hutloff A; Dittrich AM; Beier KC; Eljaschewitsch B; Kraft R; Anagnostopoulos I; Kroczek RA
Nature; 1999 Jan; 397(6716):263-6. PubMed ID: 9930702
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in the CD28/CTLA4/ICOS genes: role in malignant melanoma susceptibility and prognosis?
Bouwhuis MG; Gast A; Figl A; Eggermont AM; Hemminki K; Schadendorf D; Kumar R
Cancer Immunol Immunother; 2010 Feb; 59(2):303-12. PubMed ID: 19672595
[TBL] [Abstract][Full Text] [Related]
11. ICOS gene polymorphisms in systemic lupus erythematosus: A case-control study.
Houssaini H; Bouallegui E; Abida O; Tahri S; Elloumi N; Hachicha H; Marzouk S; Bahloul Z; Masmoudi H; Fakhfakh R
Int J Immunogenet; 2023 Aug; 50(4):194-205. PubMed ID: 37338463
[TBL] [Abstract][Full Text] [Related]
12. Methylenetetrahydrofolate reductase (MTHFR) gene 677C>T and 1298A>C polymorphisms are associated with differential apoptosis of leukemic B cells in vitro and disease progression in chronic lymphocytic leukemia.
Nückel H; Frey UH; Dürig J; Dührsen U; Siffert W
Leukemia; 2004 Nov; 18(11):1816-23. PubMed ID: 15385937
[TBL] [Abstract][Full Text] [Related]
13. Intragenic Variations in BTLA Gene Influence mRNA Expression of BTLA Gene in Chronic Lymphocytic Leukemia Patients and Confer Susceptibility to Chronic Lymphocytic Leukemia.
Karabon L; Partyka A; Jasek M; Lech-Maranda E; Grzybowska-Izydorczyk O; Bojarska-Junak A; Pawlak-Adamska E; Tomkiewicz A; Robak T; Rolinski J; Frydecka I
Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):137-145. PubMed ID: 27933341
[TBL] [Abstract][Full Text] [Related]
14. ICOS gene polymorphism may be associated with pemphigus.
Narbutt J; Lesiak A; Klich I; Torzecka JD; Sysa-Jedrzejowska A; Młynarski W
J Cutan Med Surg; 2010; 14(6):291-7. PubMed ID: 21084022
[TBL] [Abstract][Full Text] [Related]
15. [Association of ICOS and CD28 single nucleotide polymorphisms with pulmonary tuberculosis susceptibility].
Zhang X; Ji JM; Li Q; Hua TQ; Yao P; Jiang JY; Li SS; Wang FM
Zhonghua Yi Xue Za Zhi; 2019 Nov; 99(44):3466-3470. PubMed ID: 31826563
[No Abstract] [Full Text] [Related]
16. Association of T-cell regulatory gene polymorphisms with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma.
Cheng TY; Lin JT; Chen LT; Shun CT; Wang HP; Lin MT; Wang TE; Cheng AL; Wu MS
J Clin Oncol; 2006 Jul; 24(21):3483-9. PubMed ID: 16849765
[TBL] [Abstract][Full Text] [Related]
17. CD38 gene polymorphisms contribute to genetic susceptibility to B-cell chronic lymphocytic leukemia: evidence from two case-control studies in Polish Caucasians.
Jamroziak K; Szemraj Z; Grzybowska-Izydorczyk O; Szemraj J; Bieniasz M; Cebula B; Giannopoulos K; Balcerczak E; Jesionek-Kupnicka D; Kowal M; Kostyra A; Calbecka M; Wawrzyniak E; Mirowski M; Kordek R; Robak T
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):945-53. PubMed ID: 19240243
[TBL] [Abstract][Full Text] [Related]
18. Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with type 1 diabetes in the Japanese population.
Ihara K; Ahmed S; Nakao F; Kinukawa N; Kuromaru R; Matsuura N; Iwata I; Nagafuchi S; Kohno H; Miyako K; Hara T
Immunogenetics; 2001 Aug; 53(6):447-54. PubMed ID: 11685455
[TBL] [Abstract][Full Text] [Related]
19. Genetic Variation of Costimulatory Molecules, Including Cytotoxic T-Lymphocyte Antigen 4, Inducible T-Cell Costimulator, Cluster Differentiation 28, and Programmed Cell Death 1 Genes, in Iranian Patients With Leukemia.
Ramzi M; Arandi N; Saadi MI; Yaghobi R; Geramizadeh B
Exp Clin Transplant; 2020 Nov; 18(6):719-724. PubMed ID: 29697355
[TBL] [Abstract][Full Text] [Related]
20. The -137G/C Polymorphism in Interleukin-18 Gene Promoter Contributes to Chronic Lymphocytic and Chronic Myelogenous Leukemia Risk in Turkish Patients.
Yalçın S; Mutlu P; Çetin T; Sarper M; Özgür G; Avcu F
Turk J Haematol; 2015 Dec; 32(4):311-6. PubMed ID: 26376814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
